Professor Antoniades who is leading the OxQUIP Study said: 'There has been great interest in the precise measurement of abnormalities of eye movements as a way of determining the severity of Parkinson’s disease. We are delighted to be able to share the first results from this study and express our gratitude to our lovely patients for their enormous commitment and support'.
Read more (Nuffield Department of Clinical Neurosciences website)